- Home
- JKS vs AUPH Comparison
JKS vs AUPH Comparison
Compare JKS & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKS
- AUPH
- Stock Information
- Founded
- JKS 2006
- AUPH 1993
- Country
- JKS China
- AUPH Canada
- Employees
- JKS N/A
- AUPH N/A
- Industry
- JKS Semiconductors
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- JKS Technology
- AUPH Health Care
- Exchange
- JKS Nasdaq
- AUPH Nasdaq
- Market Cap
- JKS N/A
- AUPH 1.1B
- IPO Year
- JKS 2010
- AUPH 1999
- Fundamental
- Price
- JKS $18.60
- AUPH $8.04
- Analyst Decision
- JKS Hold
- AUPH Strong Buy
- Analyst Count
- JKS 5
- AUPH 2
- Target Price
- JKS $27.19
- AUPH $11.50
- AVG Volume (30 Days)
- JKS 838.5K
- AUPH 1.5M
- Earning Date
- JKS 03-26-2025
- AUPH 05-01-2025
- Dividend Yield
- JKS 16.07%
- AUPH N/A
- EPS Growth
- JKS N/A
- AUPH N/A
- EPS
- JKS N/A
- AUPH 0.04
- Revenue
- JKS $12,639,407,856.00
- AUPH $235,133,000.00
- Revenue This Year
- JKS N/A
- AUPH $11.86
- Revenue Next Year
- JKS $17.25
- AUPH $24.96
- P/E Ratio
- JKS $122.17
- AUPH $201.38
- Revenue Growth
- JKS N/A
- AUPH 33.97
- 52 Week Low
- JKS $16.70
- AUPH $4.71
- 52 Week High
- JKS $37.36
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- JKS 30.80
- AUPH 44.55
- Support Level
- JKS $20.52
- AUPH $8.37
- Resistance Level
- JKS $23.21
- AUPH $8.73
- Average True Range (ATR)
- JKS 1.28
- AUPH 0.23
- MACD
- JKS -0.42
- AUPH -0.02
- Stochastic Oscillator
- JKS 5.94
- AUPH 13.75
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.